{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:51:08Z","timestamp":1789426268022,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":326,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ZonMW IMDI\/LSH-TKI Foundation","award":["104006004"],"award-info":[{"award-number":["104006004"]}]}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Magnetic resonance-guided adaptive radiotherapy (MRgRT) enables neurovascular-sparing treatment for localized prostate cancer (PCa). The aim of this treatment is preservation of erectile function by sparing the neurovascular bundles, the internal pudendal arteries, the corpora cavernosa, and the penile bulb. Internal pudendal arteries, corpora cavernosa, and penile bulb sparing can generally be achieved in all patients, but NVB sparing can be challenging due to its proximity to the prostate and is therefore dependent on tumor location. PCa patients that have sufficient erectile function at baseline and favorable tumor characteristics might benefit from this treatment. Currently, it is unclear what proportion of patients are eligible for neurovascular-sparing treatment and to what extent this is technically feasible.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To define the eligibility and technical feasibility for neurovascular-sparing MRgRT in intermediate-risk localized PCa patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A consecutive series of men that received 5 \u00d7 7.25 gray (Gy) MRgRT for localized PCa were included. Baseline erectile function was assessed using the International Index of Erectile Function (IIEF)-5 questionnaire. Additionally, the ability of sparing the neurovascular bundles was assessed in all patients. Per neurovascular-sparing protocol, the dominant intraprostatic lesion with a 4 mm isotropic margin should receive 34.44 Gy in \u2265 99% of the volume (i.e., high-dose area). When the high-dose area directly borders or overlaps the NVB because of a dorsolateral position of the dominant intraprostatic lesion, sparing of the NVB was considered not feasible on that side.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Patient-reported IIEF-5 baseline questionnaires and the technical feasibility of NVB sparing were assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 102 men that completed the IIEF-5 questionnaire at baseline, 49.0% of patients reported to have an IIEF-5 score of \u2265 17. In those patients, the NVB could technically have been spared bilaterally in 20.0% and unilaterally in 68.0%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Our findings define the potential population for neurovascular-sparing MRgRT for localized PCa and indicate the proportion in which the NVB can technically be spared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strength &amp; Limitations<\/jats:title>\n                  <jats:p>The major strength of this study is the prospective collection of data. The limitations include that the neurovascular-sparing feasibility definition is based on pre-clinical planning data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A substantial group of 49.0% of patients in our study had mild or no erectile dysfunction at baseline. Of these patients, the NVB could technically have been spared bilaterally in 20.0% and unilaterally in 68.0% during MRgRT. Trials need to assess the effect of neurovascular-sparing MRgRT on erectile function.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T21:21:29Z","timestamp":1653340889000},"page":"1196-1200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment"],"prefix":"10.1093","volume":"19","author":[{"given":"Frederik R.","family":"Teunissen","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem R.N.","family":"van der Voort van Zyp","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.","family":"Verkooijen","sequence":"additional","affiliation":[{"name":"Imaging and Oncology Division, University Medical Center Utrecht , Utrecht , The Netherlands"},{"name":"Utrecht University , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud C.","family":"Wortel","sequence":"additional","affiliation":[{"name":"Department of Oncologic Urology, University Medical Center Utrecht , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0302-2838(03)00215-X","article-title":"Male erectile dysfunction and health-related quality of life","volume":"44","author":"S\u00e1nchez-Cruz","year":"2003","journal-title":"Eur Urol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1470-2045(18)30780-0","article-title":"Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study","volume":"20","author":"Downing","year":"2019","journal-title":"Lancet Oncol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-5347(17)53012-8","article-title":"Impotence following radical prostatectomy: insight into etiology and prevention","volume":"128","author":"Walsh","year":"1982","journal-title":"J Urol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.eururo.2012.05.046","article-title":"Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy","volume":"62","author":"Ficarra","year":"2012","journal-title":"Eur Urol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ijrobp.2014.12.017","article-title":"Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients","volume":"91","author":"Wortel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ijrobp.2016.01.031","article-title":"Late side effects after image guided intensity modulated radiation therapy compared to 3d-conformal radiation therapy for prostate cancer: results from 2 prospective cohorts","volume":"95","author":"Wortel","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1016\/S1470-2045(16)00063-2","article-title":"Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy","volume":"17","author":"Lee","year":"2016","journal-title":"Lancet Oncol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijrobp.2004.04.070","article-title":"Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI","volume":"61","author":"McLaughlin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"L41","DOI":"10.1088\/1361-6560\/aa9517","article-title":"First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment","volume":"62","author":"Raaymakers","year":"2017","journal-title":"Phys Med Biol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.semradonc.2014.02.009","article-title":"The magnetic resonance imaging-linac system","volume":"24","author":"Lagendijk","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/1754-9485.12968","article-title":"Magnetic resonance-guided radiation therapy: a review","volume":"64","author":"Chin","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/abad7d","article-title":"Anatomically-adaptive multi-modal image registration for image-guided external-beam radiotherapy","volume":"65","author":"Zachiu","year":"2020","journal-title":"Phys Med Biol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phro.2021.09.002","article-title":"Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients","volume":"20","author":"Teunissen","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/J.CTRO.2021.11.005","article-title":"Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer","volume":"32","author":"Teunissen","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","article-title":"Minimally important difference for the expanded prostate cancer index composite short form","volume":"85","author":"Skolarus","year":"2015","journal-title":"Urology"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/nejmoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.juro.2018.02.3091","article-title":"Shared decision making in prostate cancer care\u2014encouraging every patient to be actively involved in decision making or ensuring the patient preferred level of involvement?","volume":"200","author":"van Stam","year":"2018","journal-title":"J Urol"},{"key":"2023041407220004100_","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.phro.2021.07.010","article-title":"On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy","volume":"19","author":"de Muinck Keizer","year":"2021","journal-title":"Phys Imaging Radiat Oncol"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360952201298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360952201298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/7\/1196\/49877053\/jsm_19_7_1196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/19\/7\/1196\/49877053\/jsm_19_7_1196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T08:05:32Z","timestamp":1681459532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/19\/7\/1196\/6961303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,5,23]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2022.04.006","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}